Complement activation on platelets correlates with a decrease in circulating immature platelets in patients with immune thrombocytopenic purpura
Open Access
- 25 January 2010
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 148 (4), 638-645
- https://doi.org/10.1111/j.1365-2141.2009.07995.x
Abstract
The role of the complement system in immune thrombocytopenic purpura (ITP) is not well defined. We examined plasma from 79 patients with ITP, 50 healthy volunteers, and 25 patients with non‐immune mediated thrombocytopenia, to investigate their complement activation/fixation capacity (CAC) on immobilized heterologous platelets. Enhanced CAC was found in 46 plasma samples (59%) from patients with ITP, but no samples from patients with non‐immune mediated thrombocytopenia. Plasma from healthy volunteers was used for comparison. In patients with ITP, an enhanced plasma CAC was associated with a decreased circulating absolute immature platelet fraction (A‐IPF) (9/l) (P = 0·027) and thrombocytopenia (platelet count < 100 × 109/l) (P = 0·024). The positive predictive value of an enhanced CAC for a low A‐IPF was 93%, with a specificity of 77%. The specificity and positive predictive values increased to 100% when plasma CAC was defined strictly by enhanced C1q and/or C4d deposition on test platelets. Although no statistically significant correlation emerged between CAC and response to different pharmacological therapies, an enhanced response to splenectomy was noted (P < 0·063). Thus, complement fixation may contribute to the thrombocytopenia of ITP by enhancing clearance of opsonized platelets from the circulation, and/or directly damaging platelets and megakaryocytes.Keywords
This publication has 37 references indexed in Scilit:
- The ITP syndrome: pathogenic and clinical diversityBlood, 2009
- Serum complement activation on heterologous platelets is associated with arterial thrombosis in patients with systemic lupus erythematosus and antiphospholipid antibodiesLupus, 2009
- Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working groupBlood, 2009
- Complement activation triggered by chondroitin sulfate released by thrombin receptor‐activated plateletsJournal of Thrombosis and Haemostasis, 2008
- Platelet-associated complement C3 in thrombocytopenic statesBritish Journal of Haematology, 2008
- Expression of complement components and inhibitors on platelet microparticlesPlatelets, 2008
- Blood platelets activate the classical pathway of human complementJournal of Thrombosis and Haemostasis, 2006
- Platelet activation leads to activation and propagation of the complement systemThe Journal of Experimental Medicine, 2005
- Platelet‐associated immunoglobulins IgG, IgM, IgA and complement C3 in immune and nonimmune thrombocytopenic disordersAmerican Journal of Hematology, 1986